1Chobanion AV,Bakris GI,Black HR,et al.The seventh report of the Joint National Committee on Prevention,Detection,Evalution,and Treatment of High Blood Pressure.JAMA,2003,289:2560 ～ 2572
5Shah SU,Anjum S,Littler WA.Use of diuretics in cardiovascular disease Hypertension,Postgrad Med J,2004,80:271 ～ 276
6SHEEP Collaborative Research Group:Prevention of Stroke by antihypertensive drug treatment in old persons with isolated systolic hypertension:final results of the Systolic Hypertensin in Elderly Program (SHEP)JAMA,1991,265:3255 ～ 3264
7The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group,Major inhibitor or calcium channel blocker vs diuretic:The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).JAMA,2002,288(23):2981 ～ 2997
8Gosse p,Sheridan DJ,Zannad F,et al.Rogression of left ventricular hypertrophy in hypertensive patients treated with Indapamide SR 1.5 Versus.Enalapril 20:the LIVE Study.J Hypertens,2000, 18:1465 ～ 1475
9Sever PS,Dahlof H,Poalter NR,et al.Prevention of coronary and stroke events with atorvostatin in hypertensive patients who have average or lower-than-average cholesterol concentrations Loweriay Arm (ASCOT -LLA):a multicetre randomized controlled Trial.Lancet,2003, 361:1149 ～ 1158
10Poulter NR,Wedel H,Dahlef B,et al.Role of blood pressure and other variables in the differential cardiovascular event rates notes in the Anglo-Scandinavian Cardiac Outcomes Trial -Blood Pressure Lowering Arm(ASCOT-BPLA).Lancet,2005,366:907 ～ 913
